Plasma α-glutathione S-transferase: A sensitive indicator of hepatocellular damage during polymicrobial sepsis

Archives of Surgery

Volumn 135, Issue 2, 2000, Pages 198-203

  Koo, Douglas J ^a   Zhou, Mian ^a   Chaudry, Irshad H ^a   Wang, Ping ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; LACTIC ACID; LIVER ENZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME BLOOD LEVEL; LIVER CELL DAMAGE; LIVER STRUCTURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS;

EID: 0033960895     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.135.2.198     Document Type: Article

References (30)

1. Baue AE. Durham R, Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock. 1998:10:79-89.
2. Deitch EA. Animal models of sepsis and shock: a review and lessons learned. Shock. 1998;9:1-11.
3. Bone RC. Sepsis and its complications: the clinical problem. Crit Care Med. 1994; 22(suppl):S8-S11.
4. Wang P, Chaudry IH. Mechanism of hepalocellular dysfunction during hyperdynamic sepsis. Am J Physiol. 1996;270:R927-R938.
5. Downard PJ, Wilson MA, Spain DA, Matheson PJ, Slow Y, Garrison RN. Heme oxygenase-dependent carbon monoxide production is a hepatic adaptive response to sepsis. J Surg Res. 1997;71:7-12.
6. Wang P Ba ZF, Tait SM, Zhou M, Chaudry IH. Alterations in circulating blood volume during polymicrobial sepsis. Circ Shock. 1993;40:92-98.
7. Wang P, Ba ZF, Chaudry IH. Hepatic extraction of indocyanine green is depressed early in sepsis despite increased hepatic blood flow and cardiac output [published correction appears in Arch Surg. 1991;126:1093], Arch Surg. 1991; 126:219-224.
8. Wang P, Ba ZF, Chaudry IH. Hepatocellular dysfunction occurs earlier than the onset of hyperdynamic circulation during sepsis. Shock. 1995;3:21-26.
9. Redl H, Schlag G, Paul E, Davies J. Plasma glutathione S-transferase as an early marker of posttraumatic hepatic injury in non-human primates. Shock. 1995;3: 395-397.
10. van Wagensveld BA, Scheepers JJG, van Gulik TM, et al. Alpha glutathione S-transferase as novel parameter for hepatoceilular damage in the isolated perfused rat liver. Transplant Proc. 1997;29:3449-3451.
11. Trull AK, Facey SP, Rees GW, et al. Serum α-glutathione S-transferase: a sensitive marker of hepatoceilular damage associated with acute liver allograft rejection. Transplantation. 1994;58:1345-1351.
12. Beckett GJ, Chapman BJ, Dyson EH, Hayes JD. Plasma glutathione S-transferase measurements after paracetamol overdose: evidence for early hepatoceilular damage. Gut. 1985;26:26-31.
13. Hiley C, Fryer A, Bell J, Hume R, Strange RC The human glutathione S-transferases: immunohistochemical studies of the developmental expression of alpha- and pi-class isoenzymes in liver. Biochem J. 1988;254:255-259.
14. Hayes PC, Bouchier IAD, Beckett GJ. Glutathione S-transferase in humans in health and disease. Gut. 1991;32:813-818.
15. Chaudry IH, Wichterman KA, Baue AE. Effect of sepsis on tissue adenine nucleotide levels. Surgery. 1979;85:205-211.
16. Clarke H, Egan DA, Hetfernan M, et al. α-Glutathione S-transferase (α-GST) release, an early indicator of carbon tetrachloride hepatotoxicity in the rat. Hum Exp Toxicol. 1997;16:154-157.
17. Hayes PC, Hussey AJ, Keating J, et al. Glutathione S-transferase levels in autoimmune chronic active hepatitis: a more sensitive index of hepatocellular damage than aspartate transaminase. Clin Chim Acta. 1988;172:211-216.
18. Beckett GJ, Dyson EH, Chapman BJ, Templeton AJ, Hayes JD. Plasma glutathione S-transferase measurements by radioimmunoassay: a sensitive index of hepatocellular damage in man. Clin Chim Acta. 1985;146:11-19.
19. Beckett GJ, Foster GR, Hussey AJ, et al. Plasma glutathione S-transferase and F protein are more sensitive than alanine aminotransferase as markers of paracetamol (acetaminophen)-induced liver damage. Clin Chem. 1989;35:2186-2189.
20. Hussey AJ, Howie J, Allan LG, Drummond G, Hayes JD, Beckett GJ. Impaired hepatocellular integrity during general anaesthesia as assessed by measurement of plasma glutathione S-transferase. Clin Chim Acta. 1986;161:19-28.
21. Chaudry IH, Schleck S, Clemens MG, Kupper TE, Baue AE. Altered hepatocellular active transport: an early change in peritonitis. Arch Surg. 1982;117:151-157.
22. Wang P, Ba ZF, Chaudry IH. Pentoxifylline maintains hepatocellular function and improves cardiac performance during early sepsis. J Trauma. 1997;42:429-436.
23. Ridings PC, Windsor AC, Sugerman HJ, et al. Beneficial cardiopulmonary effects of pentoxifylline in experimental sepsis are lost once septic shock is established. Arch Surg. 1994;129:1144-1152.
24. Ertel W, Morrison MH, Wang P, Ba ZF, Ayala A, Chaudry IH. The complex pattern of cytokines in sepsis: association between prestaglandins, cachectin, and interleukins. Ann Surg 1991;214:141-148.
25. Wang P, Chaudry IH. A single hit model of polymicrobial sepsis: cecal ligation and puncture. Sepsis. 1998;2:227-233.
26. Wang P, Ba ZF, Chaudry IH. Mechanism of hepatocellular dysfunction during early sepsis: key role of increased gene expression and release of proinflammatory cytokines tumor necrosis factor and interleukin-6. Arch Surg. 1997;132:364-370.
27. Wang P, Ayala A, Ba ZF, Zhou M, Perrin MM, Chaudry IH. Tumor necrosis factor-α produces hepatocellular dysfunction despite normal cardiac output and hepatic microcirculation. Am J Physiol. 1993;265:G126-G132.
28. Kullak-Ublick GA, Hagenbuch B, Steiger B, Wolkoff AW, Meier PJ. Functional characterization of the basolateral rat liver organic anion transporting polypeptide Hepatology. 1994;20:411-416.
29. +-independent organic anion transporter. Proc Natl Acad Sci U S A. 1994;91:133-137.
30. Yang S, Zhou M, Koo DJ, Chaudry IH, Wang P. Pentoxifylline prevents the transition from the hyperdynamic to hypodynamic response during sepsis. Am J Physiol. 1999;277:H1036-H1044.